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Background: Several types of genetic interactions in humans can be directly or indirectly associated with the
causal effects of mutations. These interactions are usually based on their co-associations to biological processes,
coexistence in cellular locations, coexpression in cell lines, physical interactions and so on. In addition, pathological
processes can present similar phenotypes that have mutations either in the same genomic location or in different
genomic regions. Therefore, integrative resources for all of these complex interactions can help us prioritize the
relationships between genes and diseases that are most deserving to be studied by researchers and physicians.
Results: PhenUMA is a web application that displays biological networks using information from biomedical and
biomolecular data repositories. One of its most innovative features is to combine the benefits of semantic similarity
methods with the information taken from databases of genetic diseases and biological interactions. More
specifically, this tool is useful in studying novel pathological relationships between functionally related genes,
merging diseases into clusters that share specific phenotypes or finding diseases related to reported phenotypes.
Conclusions: This framework builds, analyzes and visualizes networks based on both functional and phenotypic
relationships. The integration of this information helps in the discovery of alternative pathological roles of genes,
biological functions and diseases. PhenUMA represents an advancement toward the use of new technologies for
genomics and personalized medicine.
Keywords: Functional relationships, Phenotypic relationships, Gene-disease relationships, Systems biology, Network
medicine, Network biologyBackground
Integration of clinical and biomolecular data is a key
step in the advancement of current biomedical research
and development. One of the greatest limitations of this
process is the absence of standard platforms to merge
clinical and research studies [1]. Some recent initiatives
have focused on data sharing to provide precise pheno-
typic descriptions of patients in combination with gen-
etic variation [2,3]. An effective integration of clinical
features with their molecular context, including genetic,
physical and metabolic interactions, is expected to pro-
duce new insights for biomedical research [4]. In fact,* Correspondence: medina@uma.es
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article, unless otherwise stated.the phenome and the interactome were recently listed
among the five most up-and-coming ‘omes’ that may
offer new insights in science [5]. Therefore, new integra-
tive data tools are required to establish these functional
and phenotypic links for genome-scale analyses.
Although inherited disorder databases such as OMIM
[6] and Orphanet [7], provide extremely valuable details
about the molecular nature of pathological conditions,
these databases lack direct procedures for integrating bio-
molecular information. Biomedical ontologies are promis-
ing standard resources to address a systematic integration
of phenotypes into the molecular background of mutated
genomic regions [1,8,9]. For instance, the Human Pheno-
type Ontology (HPO) currently contains over 10,000 terms
that represent each one an individual phenotype [10]. An
intuitive approach for determining similarities between sets
of ontological terms (HPO terms), that could represent thed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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their proximity in the ontology.
On the other hand, the Gene Ontology (GO) is an orga-
nized vocabulary of terms that can be subdivided into
three sub-ontologies: biological processes, cellular compo-
nents and molecular functions. Genes are associated with
consistent annotations that conform sets of GO terms that
are useful to describe the cellular and molecular events in-
volving genes [11]. Furthermore, biomolecular interac-
tomes, such as protein-protein interactions and metabolic
and gene regulatory networks, should also be used to ob-
tain a systemic view of the molecular and biochemical re-
actions related to disease-causing genes [12].
In particular, because ontologies have been beneficial in
understanding diseases as a set of phenotypes rather than
conceptual entities, studying correlations among distinct
biological conditions affected by genetic variations would
be very useful [13].
The main purpose of this application is to provide a
friendly platform that facilitates the analysis of phenotypic
and functional information and the discovery of emergent
or unnoticed relationships between pairs of genes or
genetic diseases. PhenUMA also complies useful bio-
logical information from different interactomes, includ-
ing protein-protein interactions from STRING [14] and
metabolic flux correlations [15]. Altogether, PhenUMA
may be useful for discovering interesting new insights on
or features shared by human diseases, increasing the po-
tential for diagnosis and pharmacological intervention.
Implementation
Knowledge base: data processing and storage
The initial stages of the development of PhenUMA were
focused on building a consistent knowledge base, and sub-
sequent efforts were dedicated to design a user-friendly
web application. The knowledge base contains all of the
information necessary to create the output networks, and
the source data were retrieved from consolidated data-
bases or from inferred relationships determined using dif-
ferent data processing methods (Figure 1A, schematic
representation of the knowledge base). The web interface
was implemented to make the query execution easier and
to allow the visualization of outcome networks according
to the Cytoscape Web 1.0.3 utility [16]. The tool was de-
veloped in Java, and the database was built using MySQL
5.0.45. PhenUMA and other resources such as tutorials
and downloadable processed data are available on the web
(http://www.phenuma.uma.es/). An illustrative example of
all of the types of gene-gene relationships is shown in
Figure 1B.
Known relationships
The Gene Map file provided by OMIM was used to ex-
tract 4,261 relationships between 2,794 OMIM genes and3,486 OMIM phenotypes; OMIM genes were mapped to
their GeneID. The PhenUMA knowledge base also con-
tains the associations between Orphanet diseases and
genes. This information was extracted from the file “Dis-
eases with their associated genes”, included at Orphadata
[17], and was used to develop 4,472 connections between
2,614 GeneIDs and 2,555 orphan diseases. We also in-
cluded the diverse interactomes of human protein-protein
interactions (96856 relationships) that were found with
STRING [14] and 9812 gene pairs that had positive flux
correlations in the metabolic network [15].
Inferred relationships
The inferred relationships between genes or diseases and
orphan diseases are due to binary relationships, resulting
in four different types of networks. For instance, an in-
ference between two genes will be considered if at least
one or more OMIM/Orphan diseases are associated with
both genes. A stronger interaction between two genes
will be considered when they share more than one dis-
ease. Overall, the scores that indicate the intensity of the
relationship is the number of disorders involved in the
relationship. The same criterion was applied to establish
the inferred relationships between OMIM and Orphan
disorders. In this case, the number of genes shared by
the disorders is considered the score.
Semantic similarity relationships
HPO and GO were used to calculate the phenotypic
similarities between genes or diseases and the functional
similarities between genes, respectively. We used Onto-
logizer 2.0, an open-source tool, to determine the func-
tional similarities, and it was also adapted to compute
phenotypic similarities [18]. Each gene or disease is rep-
resented by a set of terms that defines its functional or
phenotypic profile. Only the most specific terms are in-
cluded in the annotation files because the “true path
rule” is met. This rule implies that each object related to
a term also relates to all of the ancestors of this term to
the root. For instance, the OMIM (MIM# 200500) dis-
order “Acheiropody” is associated with both “Humeral
hypoplasia” (HP:0005792) and all of its ancestors, such
as “Aplasia/Hypoplasia of the humerus” (HP:0006507).
Two different semantic similarity measures that are
based on Resnik’s approach were used to calculate the
functional similarity among genes and the phenotypic simi-
larity among phenotypic profiles. Both measures are based
on the concept of information content (IC), which is calcu-
lated using the logarithm of the probability of each term
(the ratio of the number of annotations of a term to the
total number of annotations). If the probability decreases,
then the IC increases, and consequently, the specificity and
the informativeness also increase. The semantic similarity
between two terms of a given ontology, as proposed by
Figure 1 PhenUMA knowledge base. A: Schematic representation of the PhenUMA knowledge base contents. Three types of relationships are
included in the knowledge base: i) “known relationships” (solid lines) were extracted from the databases OMIM, Orphanet and STRING and also include the
metabolic interactions from Veeramani and Bader [15]; ii) “inferred relationships” (dashed lines) were taken from the OMIM and Orphanet known
relationships; and iii) “semantic similarity relationships” (dotted lines). For the semantic similarity relationships, scores were calculated using the HPO and
GO. Genes (red triangles), OMIM diseases (yellow circles) and Orphanet diseases (blue octagons) are the components of these relationships. This schematic
describes how inferred relationships were determined from known relationships; that is, how the dashed lines were deduced from the solid lines.
B: Illustrative example of integration between phenotypic and functional gene-gene relationships as retrieved in PhenUMA for ornithine transcarbamylase
(OTC; MIM# 300461) at a medium confidence level.
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ative common ancestor (MICA). The similarity score be-
tween groups of terms was obtained by selecting the
maximum MICA from all possible pairs of terms. This al-
gorithm has produced suitable results for calculating func-
tional similarity among genes on several occasions [20-22]
and is based on the most specific GO terms. This allows re-
lating genes considering the closest molecular mechanisms
between them. Regarding to the phenotypic similarity, we
have used the complete set of symptoms (HPO terms), as-
sociated with a disease or gene, because is more adequate
to compare phenotypic profiles. For this reason, we used the
method applied by Robinson and co-workers [23], based on
Resnik combined with the best-match average. Briefly, if p1
and p2 are two different phenotypic profiles, the semantic
similarity of this pair of HPO terms is defined as:sim p1; p2ð Þ ¼
X
ti∈ p1
maxtj∈p2sim ti; tjð Þ
p1j j ð1Þ
where ti and tj represent each HPO term that is in-
cluded in the profiles p1 and p2. This equation is not
symmetric. Robinson and co-workers use a symmetric
version for HPO [23]:
simsymmetric p1; p2ð Þ ¼ sim p1; p2ð Þ2
þ sim p2; p1ð Þ
2
ð2Þ
The annotation files that include the relationships be-
tween genes or diseases and their ontological profiles were
required to calculate semantic similarity. We downloaded
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relates GO terms to human genes, from the GO website.
Two additional files, named “phenotype_annotation.tab” for
OMIM and orphan diseases and “gene2phenotype.txt” for
gene annotations, were downloaded from the HPO website.
In this case, only the annotations of the descendent terms
from the “Phenotypic Abnormality (HP:0000118)” term
were used for the calculations. This process compiled the
associations of 4,965 OMIM diseases plus 3,143 orphan dis-
eases with sets of HPO terms and relationships between
1,806 genes and HPO terms. Table 1 summarizes the differ-
ent types of semantic similarities processed by PhenUMA.
Optimal threshold selection of semantic similarities
Each type of semantic similarity calculation requires the
establishment of an optimal statistical threshold to dif-
ferentiate between significant and non-significant simi-
larity scores. Therefore, a minimal meaningful threshold
was estimated for each class of phenotypic and func-
tional similarity listed in Table 1. Four different refer-
ence datasets were generated from the information in
the PhenUMA knowledge base: one for each phenotypic
similarity (OMIM-OMIM, Orphan Disease-Orphan Dis-
ease and Gene-Gene) and another for all different types
of functional similarity. In particular, we compared each
dataset of disease pairs, which was inferred from the gene-
disease association studies found in OMIM and Orphanet,
to the phenotypic similarities between the diseases. The
dataset for phenotypic similarities between genes was
generated from the union of all inferred pairs obtained
from OMIM and Orphanet. The fourth reference dataset
resulted from the combination of interactomes from both
metabolic and protein-protein interactions; the same data-
set was used for all of the functional similarities.Table 1 Summary of main relationships in the knowledge bas
Type of network Type of interaction (source
Phenotypic relationships
OMIM-OMIM Inferred by Genes (OMIM)
OMIM-OMIM Phenotypic Similarity (HPO)
Orphan Disease-Orphan Disease Inferred by Genes (Orphanet
Orphan Disease-Orphan Disease Phenotypic Similarity (HPO)
Gene-Gene Inferred by OMIM (OMIM)
Gene-Gene Inferred by Orphan Disease (
Gene-Gene Phenotypic Similarity (HPO)
Functional relationships
Gene-Gene Functional Similarity (GO Bio
Gene-Gene Functional Similarity (GO Cel
Gene-Gene Functional Similarity (GO Mo
Gene-Gene Protein-protein interactions (
Gene-Gene Metabolic interactions [Veera
aResulting relationships to apply the respective cutoff for low confidence level.Initially, we built a binary classifier system that com-
pares all of the computed scores between semantically
similar genes or disease pairs with their respective refer-
ence datasets. However, the estimated thresholds in each
ROC curve were meaningful (Additional file 1), but they
are impractical as optimal cutoffs because of the large
size of the resulting networks. Therefore, we analyzed
cutoff variations in the phenotypic similarity datasets
using a similar approach as in one of our recent studies
[13]. First, we removed all pairs of genes or diseases that
had a similarity score below the 95th percentile. Next, we
studied both the influence of cutoff variations on the
number of gene or disease entries and the resulting Jac-
card’s similarity coefficients when comparing the semantic
similarity networks to their respective reference datasets
network (Figure 2). More specifically, the Jaccard’s similar-
ity coefficient represents the number of intersected pairs
of gene or disease entries divided by the number of pairs
of entries in the union.
As shown in Figure 2A, the number of genes and diseases
began to decrease at the 98th percentile of all phenotypic
similarities. Robinson’s measurement clearly conserved
more genes and diseases at the same cutoff points than
Resnik’s did measurement (solid lines above dashed lines,
Figure 2A). The phenotypic similarity networks that result
in different cutoffs are more similar to the reference data-
set networks as we increase the similarity score cutoffs
(solid lines above dashed lines, Figure 2B). This trend is
especially notable for the evolution of Jaccard’s similarity
coefficient for the phenotypic similarity gene networks at
the 98th percentile, where Resnik’s measurement has a
maximum similarity of approximately 3% and Robinson’s
one increases up to 10%. Indeed, this coefficient even









logical Process) 9123 486982a
lular Component) 6046 565739a
lecular Function) 8087 397683a
STRING) 10316 96856
mani and Bader[15]] 535 9812
Figure 2 Effects of phenotypic similarity cutoff variations on
the number of elements and Jaccard coefficients. Computed
phenotypic similarities for gene pairs (blue squares), OMIM disease pairs
(red circles) and Orphanet disease pairs (green triangles) were filtered at
the 95th percentile, and different cutoff scores corresponding to the
95th, 98th, 99th and 99.5th percentiles were used. The Resnik and
Robinson measurements are shown as solid and dashed lines,
respectively. A: Variations in the number of genes and diseases that are
involved in phenotypic similarities at increasing values of the similarity
score. B: Variations of the Jaccard’s similarity coefficients calculated from
the resulting intersection between the phenotypic similarity-based
networks and their respective inferred networks is represented as the
distinct similarity scores.
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similarity disease networks also had slightly higher Jac-
card’s similarity coefficients for Robinson’s measurement
from the 95th percentile to the top similarity score (red cir-
cles and a solid line for OMIM diseases and a green line,
Figure 2B).As it was foreseeable, the semantic similarity measure-
ment applied by Robinson produced better performance
for phenotypic similarities than Resnik’s method (see
Additional file 1). This analysis revealed the 98th per-
centile as a suitable threshold that provided a balanced
tradeoff between a gain in specificity for phenotypic
similarities and a loss of information for disease and
gene pairs (Figure 2). For this reason, we selected the
98th percentile of Robinson’s measurement as the lowest
similarity value and the minimal appropriate cutoff to
build phenotypic similarity based networks.
On the other hand, functional similarities are strongly
dependent on large ontological domains that cluster genes
with similar scores. Consequently, we set the lower cutoff
at the 99.5th percentile, which considerably increases the
similarity’s significance and reduces noise from non-
informative similarities. Therefore, phenotypic- and
functional similarity-based networks were stored in the
knowledge base using the 98th and 99.5th percentile as
the minimal levels of confidence, respectively (Table 1).
All of the scores were normalized following a min-max
normalization method, and therefore the scores take values
between 0 and 1, where 0 corresponds to the minimal
score greater than the cutoff, and 1 represents the highest
score for semantic similarity. This method results in
confident semantic similarity relationships and a manage-
able size of networks to be processed by PhenUMA.
Results
Network building process
PhenUMA allows the retrieval of information related
with a set of genes, diseases or phenotypes of interest.
Figure 3 shows the building network stages for each type
of input and output. When a query is executed, firstly a
seed network is created from the input reported by the
user; subsequently, this network is populated with the
relationships included in the database for the type of
data related (Figure 3B). For example, if a phenotypic
similarity network is requested for one gene or one list
of genes, the resulting network is populated with the
functional, protein-protein interaction, metabolic and in-
ferred relationships (see an example for ornithine trans-
carbamylase in Figure 1B). PhenUMA allows users to
select among three different levels of confidence, termed
low, medium and high, for both phenotypic similarities
(the 98th, 99th and 99.5th percentiles, respectively) and
functional similarities (the 99.5th, 99.8th and 99.9th per-
centiles, respectively).
The process of network building is quite different if a
set of phenotypes is used as input. In this case, the set of
phenotypes is considered as a new phenotypic profile. The
similarity between this set and the phenotypic space of
other genes or diseases is calculated using Robinson’s se-
mantic similarity measure. In the outcome network, the
Figure 3 Building network process. A: Input provided by the user of PhenUMA. Gene-Gene network building allows a set of genes or diseases
as input (OMIM or Orphan diseases). In case of providing a disease list, genes associated with each disease (OMIM or Orphanet associations) are
use to create the gene-gene network in the building network stage. Disease-Disease network can relate OMIM diseases or Orphan diseases and in
both cases the input type are similar: a list of diseases or a set of genes. Phenotype query network building require of a set of phenotypes (HPO)
as input, which is taken as a phenotype profile. B: Building network stage is divided in two parts: the seed network building that contains the
relationships between de input set (genes, diseases or phenotypes) and the rest of elements included in the database and the network
enrichment that consist in the addition of the rest of relationships included in the knowledge base (see Figure 1) between the elements related
in each network.
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significant relationships (P-value <0.05) among the genes
or diseases are included. P-values are the probability of
obtaining a greater score, between the input query and
each gene or disease annotated to the ontology, in the
comparison with a random set of phenotypes with same
size as the input set. The calculation of P-values was per-
formed using the Monte Carlo method based on the gen-
eration of random samples (1000000 of samples for each
size of query from 1 to 10) of phenotypes to calculate a es-
timation of the probability of a greater score, similar to
those used in Phenomizer [24]. For example, if the P-value
associated to the score of the relationships between a
query of five phenotypes and a disease is 5 · 10−6 means
that only 5 of 1000000 random combinations of fivephenotypes provides a greater score that the input set in
the comparison with a specific disease.
Novel pathological relationships between genes
The gene-gene network obtained using semantic similar-
ity methods and the gene-gene inference network from
known interactions (both OMIM and Orphanet) were
compared to study their mutual coverage. Three distinct
subsets were distinguished (Figure 4): inferred pairs of
genes that are not included in phenotypic similarity gene
network (Inferred OUT), inferred pairs of genes that are
in the phenotypic similarity gene network (Inferred IN)
and novel pairs of genes that are exclusively in the pheno-
typic similarity gene network. These latter genes represent
more than 90% of all computed phenotypic similarities
Figure 4 Subsets of inferred and phenotypically similar gene pairs. Venn diagram showing the distribution of gene pairs between a dataset
of inferred relationships (from the union of OMIM and Orphanet) and the phenotypic similarity gene network at a low level of confidence
corresponding to the 98th percentile.
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because the involved genes are not co-associated with the
same genetic disease based on the current information in
OMIM and Orphanet. Notably, 1606 genes in OMIM and
792 genes Orphanet are associated with only one mono-
genic disease so they would appear as unconnected in in-
ferred networks. Nevertheless, more than 49% and 61% of
these genes, respectively, are linked to other genes with
phenotypic similarity in PhenUMA.
PhenUMA can detect whether genes are directly or in-
directly involved in similar pathological events via the
semantic similarity of their phenotypic profiles. For in-
stance, some mutations in carbonic anhydrase II (CA2;
MIM# 611492) are uniquely related to a monogenic dis-
ease named osteopetrosis with renal tubular acidosis
(MIM# 259730 or ORPHA 2785). When using as output
network of gene-gene semantic similarities from HPO
with low confidence in PhenUMA, CA2 shows phenotypic
similarities to TNFSF11 (MIM# 602642), TBCE (MIM#
604934) and SLC4A1 (MIM# 109270). CA2 also has a
physical interaction with SLC4A1 and a functional similar-
ity for a biological process with TNFSF11. In agreement
with the whole set of HPO annotations for CA2, the
most specific clinical features for this gene include: dis-
tal renal tubular acidosis (HP:0008341), extramedullary
hematopoiesis (HP:0001978), periodic hypokalemic paresis
(HP:0008153), optic nerve compression (HP:0007807), ele-
vated serum acid phosphatase (HP:0003148) and diaphy-
seal sclerosis (HP:0003034). TNFSF11 presents phenotypic
similarities with CA2 for extramedullary hematopoiesis
(HP:0001978), cranial nerve compression (HP:0001293),
diaphyseal sclerosis (HP:0003034), hepatosplenomegaly(HP:0001433) and cranial hyperostosis (HP:0004437).
Indeed, TNFSF11 and CA2 are positive regulators in bone
remodeling (GO:0046852) and reabsorption (GO:0045780).
SLC4A1 shares phenotypes with CA2, including peri-
odic paralysis (HP:0003768), renal tubular acidosis
(HP:0001947) and hypokalemia (HP:0002900) and is
also biochemically related to CA2 by physical interac-
tions. TBCE and CA2 are not functionally associated,
but both genes are associated phenotypically with renal
tubular dysfunction (HP:0000124) and increased bone
mineral density (HP:0011001). This example illustrates the
novel phenotypic similarities for CA2 that are integrated
with other functional relationships and additional informa-
tion processed by PhenUMA. All of these results can be re-
trieved from PhenUMA combining network visualization,
informative panels and other features such as phenotypic
and functional enrichment analysis of selected nodes in
resulting networks.
Clustering diseases by phenotypic similarity
PhenUMA allows users to obtain coherent disease and
gene clusters related to a particular disease, gene or set of
phenotypes for research purposes. As an example, we will
examine succinic semialdehyde dehydrogenase deficiency
(SSADHD; MIM# 271980), also known as 4-Hydroxy
butyric aciduria, a rare inborn error of metabolism associ-
ated with mutations in Locus ALDH5A1 (ALDH5A1;
MIM# 610045). We used PhenUMA to search for all of
the phenotypic similarities to SSADH deficiency at each of
the confidence levels of low, medium and high. These re-
sults show how different clusters of diseases are generated
and belong to distinguishable groups according to their
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cutoff for phenotypic similarity gives four large overlapped
and densely interconnected clusters of disorders associ-
ated with epilepsy, seizures, neurodegenerative processes,
neurophysiological abnormalities and behavioral problems
(Figure 5A). SSADH deficiency has a higher frequency of
connections to the disorders that involve convulsions, epi-
lepsy or changes in behavior, and the connection becomes
more evident when we increase the similarity score to the
medium level of significance (Figure 5B). In this case, the
established clusters have a more clearly defined structure
and relationships to SSADH deficiency. Indeed, three non-
overlapped clusters are apparent in Figure 5B. However,
although the phenotypic coherence increased, the intercon-
nections between clusters (OMIM diseases) remained
abundant in the resulting network (Figure 5B). Therefore,
we constrained the query to the most significant pheno-
typic similarities for SSADH deficiency by selecting the
“high confidence” option in PhenUMA.
At least three types of specific phenotypes including be-
havioral or psychiatric abnormalities (HP:0000708), autismFigure 5 Phenotypically similar disorders associated with SSADH defi
for SSADH deficiency (MIM# 271980) at different levels of confidence A: Lo
results that were edited to highlight the main clinical features associated w(HP:0000717) and generalized seizures (HP:0002197) in-
volve a succinic semialdehyde dehydrogenase deficiency
(Figure 5C). Interestingly, the clusters of disorders associ-
ated with behavioral and seizure abnormalities are intercon-
nected by two monogenic diseases: succinic semialdehyde
dehydrogenase deficiency (SSADHD, MIM# 271980) and
early infantile epileptic encephalopathy-9 (EIEE9, MIM#
300088). Table 2 shows the results of a phenotypic enrich-
ment for the 19 OMIM disorders shown in Figure 5C using
the hypergeometric test provided by PhenUMA. These ob-
servations demonstrate how phenotypic similarity and
network-based methods are useful in studying the pathobi-
ology of human diseases. In particular, this method also
provides an alternative procedure to understanding groups
of diseases that share similar clinical features.
Comparison with other resources
A comparison between PhenUMA and related web-based
tools was performed to analyze several criteria, including
the integration of information, the phenotypic information
used to relate genes and diseases, the visualization ofciency at different confidence levels. PhenUMA results of the query
w, B: Medium and C: High. All panels are screenshots of the PhenUMA
ith each OMIM disease cluster.
Table 2 Phenotypic enrichment of SSADHD and high confidence similar disorders




HP:0002197 Generalized seizures 70 13 4.87E-19 (607628, 607681, 611364, 600669,
608096, 607631, 607208, 300423,
608217, 600131, 271980, 604827,
300088)
HP:0002123 Generalized myoclonic seizures 27 6 2.62E-08 (611364, 600669, 607631, 607208,
271980, 604827)
HP:0002133 Status epilepticus 11 4 3.53E-06 (608096, 607208, 271980, 300088)
HP:0002392 EEG with polyspike wave complexes 4 3 1.35E-05 (607681, 600669, 600131)
HP:0000717 Autism 35 4 5.29E-04 (606053, 238350, 209800, 271980)
HP: 0000708 Behavioural/Psychiatric Abnormality 406 8 4.47E-03 (143465, 606053, 238350, 167870,
209800, 271980, 300088, 190100)
HP:0001311 Neurophysiological abnormality 83 4 1.65E-02 (607681, 600669, 600131, 271980)
HP:0000739 Anxiety 33 3 1.71E-02 (167870, 271980, 190100)
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summarizes all of the features considered when compar-
ing PhenUMA with other, similar tools.
PhenUMA aims to integrate information using network-
based methods, and GeneMANIA is a useful example of
the integration of biomolecular data [25]. This web inter-
face generates gene networks based on many different
types of relationships such as protein and genetic interac-
tions, pathways, coexpression, colocalization and protein
domain similarities. However, in addition to functional in-
teractions, PhenUMA also includes the pathological and
phenotypic relationships between genes as shown in
Table 3. Other tools, such as MalaCards, integrate the
pathological and functional information related to human
diseases by supplying an extensive repository of different
information, where mouse phenotypes are used instead of
human phenotypes [26]. Two notable tools that integrate
phenotypic information are Phenomizer and Phenom-
eNET, but both tools are not specifically designed to inte-
grate this information with biomolecular data, which is
required for an extensive systemic analysis. Phenomizer
demonstrates the potential benefits of semantic- and
ontology-based methods when they are applied for the
systematic diagnosis of diseases [24]; these features were
also included in PhenUMA. PhenomeNET is another tool







PhenUMA Yes IC-based Yes
Phenomizer Yes IC-based No
GeneMania No - Yes
PhenomeNET Yes Jaccard’s Index Yes
MalaCards No* MCRDS Yes
*Mouse Phenotypes (from Mammalian Phenotype Ontology) are related with the dbetween a single OMIM/Orphan disease, gene or pheno-
type and other genes or diseases, including cross-species
information [27] and uses a Jaccard’s index to calculate
phenotypic similarity. Conversely, the similarity score be-
tween the diseases as calculated by MalaCards, named the
Malacards Composite Related Diseases Score (MCRDS),
combines an enrichment analysis of disease descriptors
with different search engine ranks [26]. The resulting
ranked scores in MalacCards are also used to build disease
networks based on their shared disease descriptors, but it
uses murine phenotypes instead of human phenotypes.
PhenomeNET and Phenomizer are the most comparable
to PhenUMA. Therefore, a more systematic comparison
was performed between the results of PhenUMA and Phe-
nomeNET. To do so, we downloaded the file “borderflow-
0.1”, which contains relationships and similarity scores
between the phenotypes of several species, such as worm,
fly, rat, mouse, zebra fish and human, from the Phenom-
eNET website. Given this cross-species phenotype network,
we selected only OMIM disease pairs. A ROC curve was
built using the same reference set of inferred relationships
between OMIM diseases that share one or several genes.
The resulting ROC curves from Resnik’s and Robinson’s
measures give better results than those provided by Phe-
nomeNET (Figure 6A). We analyzed the fraction of ex-








Yes Yes Yes Yes
Yes No Yes No
No Yes Yes Yes
Yes Yes Yes No
Yes Yes No Yes
isease queried but not Human Phenotypes.
Figure 6 ROC curve and false discovery rates (FDR) for phenotypic similarities between diseases provided by PhenUMA and
PhenomeNET. A: ROC curves for phenotypic similarities between OMIM diseases. For all the cases we used the same reference dataset. This
dataset are all inferred OMIM disease pairs that are those diseases associated with the same gene/s. It is noteworthy that the results from
Robinson and Resnik are equivalent to those in Additional file 1: Figure S1A and S1B, respectively, B: FDR for increasing values of phenotypic
similarity scores.
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http://www.biomedcentral.com/1471-2105/15/375rate for each system (Figure 6B). In this case, we observed a
lower false discovery rate for PhenUMA, which uses the
Robinson’s measure, compared to the similarity score com-
puted using PhenomeNET (Figure 6B). However, Phenom-
eNET gives a lower fraction of expected false positives than
the classical Resnik’s measure.
Finally, using the lists of diseases that are phenotypic-
ally similar to SSADH deficiency (OMIM #271980), we
made a direct comparison of the results obtained from
PhenUMA, Phenomizer and PhenomeNET. First, these
lists were ranked by their phenotypic similarity to
SSADH deficiency, and the top 10 and 50 of the OMIM
diseases were selected. Then, we performed a phenotypic
enrichment of each top list using a hypergeometric test
and its corresponding Bonferroni correction. In the
Table 4, we summarized the results of the phenotype en-
richments by comparing them both to the list of pheno-
types that are related to SSADH deficiency and to their
respective IC values that indicate their level of specifi-
city. For instance, status epilepticus showed the highest
IC value, which indicates that it is the most specific
phenotype associated with SSADH deficiency (Table 4).
PhenUMA gives a significant enrichment of status epi-
lepticus in the top 10 and 50 of ranked diseases, while no
significant enrichment was found for Phenomizer and
PhenomeNET. Consequently, the diseases more pheno-
typically similar to SSADH deficiency are also associated
with status epilepticus in PhenUMA. In addition, from
the 22 phenotypes annotated for SSADH deficiency, we
can count 9 significant phenotypes in the top 50 of the
similar diseases retrieved by our system (Table 4).
However, Phenomizer and PhenomeNET have only 4 and
5 phenotypes with a P-value below 0.05, respectively.
Interestingly, there is a gradual enrichment of specificphenotypes in PhenUMA and Phenomizer as we con-
strain the conditions from the top 50 to the top 10
(Table 4). In contrast, the enrichment of phenotypes in
PhenomeNET gives phenotypes with low IC values.
Discussion
PhenUMA provides an integrative framework for biomed-
ical and biomolecular relationships among genes and gen-
etic diseases by combining network methods and semantic
similarity calculations. This integration process uses patho-
logical and functional information from different databases,
inferences of already known relationships and computed
semantic similarities using biomedical ontologies (HPO
and GO), as shown in Table 1. To achieve this goal, Phe-
nUMA uses several biocomputational technologies to unify
in the same platform information that apparently is uncon-
nected. One of the primary applications of this platform is
to explore how disease-associated genes are phenotypically
and functional associated. PhenUMA was shown to be use-
ful for discovering novel pathological relationships between
genes and as a new way to study groups of diseases based
on the similarity of their phenotypic profiles. These pheno-
typic similarity relationships are strongly dependent on the
ontology structure and the threshold selection. The Hu-
man Phenotype Ontology is a standardized platform with
recognized clinical value [24], but the selection of an opti-
mal threshold requires reference datasets to assess the pre-
cise significance of the similarity score. In PhenUMA, we
set a score for semantic similarity that is suitable to detect
implicit relationships in databases. The reference datasets
used here were built from the inferred relationships (the
union of the sets Inferred IN and Inferred OUT of Figure 4)
of disease or gene pairs from OMIM or Orphanet that
share at least one disease or one gene, respectively. Each
Table 4 Phenotypic enrichment of OMIM diseases similar to SSADH Deficiency (OMIM 271980)
Bonferroni corrected P-values
PhenUMA Phenomizer PhenomeNET
Phenotypes IC Top 10 Top 50 Top 10 Top 50 Top 10 Top 50
Status epilepticus 0,709 7,36E-03 1,49E-05 6,81E-01 5,83E-01 1 1,39E-01
Absence seizures 0,681 1,21E-02 6,75E-11 1,02E-02 1,91E-11 2,99E-01
Hyperkinesis 0,658 1 1 1
Hallucinations 0,613 7,55E-01 1 1
Generalized myoclonic seizures 0,604 6,21E-04 2,30E-03 5,20E-04 6,52E-04 1 1
Anxiety 0,581 6,90E-02 6,47E-03 5,78E-02 4,79E-01
Autism 0,574 7,76E-02 1,51E-01 5,67E-01 1
Psychosis 0,565 1 6,61E-04 1 1 1
Generalized tonic-clonic seizures 0,562 1,19E-09 3,54E-29 2,05E-05 2,20E-25 1,44E-13 1,26E-14
Delayed speech and language development 0,543 1 1 1 1
Aggressive behavior 0,540 1 6,50E-09 1 1 1
Hypokinesia 0,491 1 1
EEG abnormality 0,489 1 4,31E-14 1 5,47E-05 1 1
Increased body weight 0,486 1
Hyperactivity 0,484 3,50E-03 1 1 1
Hyporeflexia 0,437 1 1 1,14E-01
Motor delay 0,420 1 1 1
Ataxia 0,317 1 1 1 8,27E-21
Abnormality of eye movement 0,307 8,75E-01 1,54E-01 1,10E-19
Muscular hypotonia 0,281 1 1 2,74E-07
Intellectual disability 0,214 1 1 8,65E-01 1,72E-03
Abnormality of metabolism/homeostasis 0,123 1 1 1 1 1 1
In bold, Bonferroni corrected P-values ≤0.05, hypergeometric tests.
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example, an inferred relationship between two disorders,
where both present genetic variations associated with
the same gene, might indicate a potential functional de-
pendence between these pathologies and the molecular
mechanisms involving this gene. If these disorders are
phenotypically similar, it supports the hypothesis that
perturbations in this gene will produce similar clinical
features. Therefore, the resulting thresholds for pheno-
typically similar diseases are the minimal scores that
distinguish disease pairs that are potentially related to
the same molecular background. On the other hand, an
inferred relationship between genes suggests that both
genes could be part of close functional modules. There-
fore, mutations in these genes may be canalizing per-
turbations effects to cause the same clinical features.
The resulting optimal threshold is useful for determin-
ing the minimal similarity score for two genes that may
be involved in the same pathological processes.
Our analysis provides evidence that Robinson’s measure-
ment, which uses the entire phenotypic profile of disor-
ders to calculate similarities between genes and diseases,performs better than the classical Resnik’s measurement
(Additional file 1: Figure S1). As the similarity score in-
creases, it implies a higher phenotypic specificity between
gene and disease pairs. Robinson’s measure conserves
more information (Figure 2A) and the resulting networks
are more similar to the used reference datasets (Figure 2B).
In addition, PhenUMA provides more confident pheno-
typic similarities between OMIM diseases than do other
similar systems, such as PhenomeNET (Figure 6A and B).
To compute similarity scores, both systems use the entire
phenotypic profile of OMIM diseases instead of the most
specific phenotype in the relationship. It means that the
entire phenotypic profile of a disease will be more inform-
ative than the most specific phenotype, reinforcing the
need for deep phenotyping [1]. Our system also has a
lower false positive rate than PhenomeNET (Figure 6B). A
possible explanation for these differences is that Phenom-
eNET uses cross-species information, so it may be influen-
cing the similarity scores.
Furthermore, we also used a case of study of SSADH de-
ficiency to show how phenotypic similarity generates com-
prehensive clusters of diseases in PhenUMA (Figure 5).
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diseases by their similarity to SSADH deficiency are quite
different for PhenUMA and Phenomizer compared to
PhenomeNET. For instance, PhenUMA and Phenomizer,
which use the same similarity measures, are more signifi-
cantly enriched with the clinical features associated with
SSADH deficiency than those of PhenomeNET (Table 4).
Our results suggest that clusters of phenotypically similar
diseases are more coherent in PhenUMA compared to
other current similar systems.
Our assessment of the integration of functional and
phenotypic relationships was based in a network compari-
son and correlation analysis of distinct subsets of pairs of
genes. In general, phenotypic similarity clusters genes that
interact in close molecular and cellular biological condi-
tions. While it remains difficult to systematically distinguish
between meaningful relationships and background noise,
phenotypic similarity gene network is significantly enriched
with functional interactions. For instance, the resulting net-
work of gene pairs from the “Novel subset” is coherent and
abundant in functional interactions, especially for protein-
protein interactions and functional similarities in biological
process (see Additional file 1). In general, protein-protein
interactions and pairs of genes with similar cellular localiza-
tions likely give more direct evidence for the inferred
pathological relationships [28], as observed for the “Inferred
IN” and “Inferred OUT” subsets (see Additional file 1).
Notably, these results may be influenced by a biomedical
research bias, especially for genes that are associated with
the same genetic disease [29,30]. Nevertheless, PhenUMA
includes the option to filter results with the highest seman-
tic similarity by offering a range of specificity of interactions
between genes or diseases. Future improvements on this
feature will be needed to extend the validity and the variety
of biological interactions.
Conclusions
In conclusion, the information produced by PhenUMA
integrates clinical and biomolecular information to sup-
ply wider insights on the phenotypic and molecular
characteristics of pathological processes. This tool is use-
ful to help clinical and basic researchers to reinterpret
their results and to redesign experiments by considering
apparently non-related elements a priori. PhenUMA
users can download detailed tutorials and stored net-
works from the knowledge base on the website. Returns,
including comments and criticisms, from final users will
be considered for future improvements of this tool.
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